immune system
• lovastatin administration fails to increase regulatory T cell recruitment to sites of inflammation in a model of delayed-type hypersensitivity
|
• mice are refractory to the anti-inflammatory response of the statin drug lovastatin in delayed-type hypersensitivity
• the anti-inflammatory response of lovastatin is dependent on recruitment of T-regulatory cells to sites of inflammation which fails to occur in these mice
|
hematopoietic system
• lovastatin administration fails to increase regulatory T cell recruitment to sites of inflammation in a model of delayed-type hypersensitivity
|